Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-08-17

AUTHORS

Fei Liu, Sajad Rajabi, Chunhua Shi, Ghazale Afifirad, Nazanin Omidi, Ebrahim Kouhsari, Saeed Khoshnood, Khalil Azizian

ABSTRACT

BackgroundMethicillin-resistant Staphylococcus aureus (MRSA) infections are considered an important public health problem, and treatment options are limited. Accordingly, in this meta-analysis, we analyzed published studies to survey in vitro activity of recently approved antibiotics against MRSA isolates.MethodsWe searched electronic databases; PubMed, Scopus, and Web of Science to identify relevant studies (until November 30, 2020) that have focused on the in vitro activity of telavancin, dalbavancin, oritavancin, and tedizolid against MRSA isolates. Statistical analyses were conducted using STATA software (version 14.0).ResultsThirty-eight studies were included in this meta-analysis. Overall in vitro activity of tedizolid on 12,204 MRSA isolates was 0.250 and 0.5 µg/mL for MIC50 and MIC90, (minimum inhibitory concentration at which 50% and 90% of isolates were inhibited, respectively), respectively. The overall antibacterial activity of dalbavancin on 28539 MRSA isolates was 0.060 and 0.120 µg/mL for MIC50 and MIC90, respectively. The overall antibacterial activity of oritavancin on 420 MRSA isolates was 0.045 and 0.120 µg/mL for MIC50 and MIC90, respectively. The overall antibacterial activity of telavancin on 7353 MRSA isolates was 0.032 and 0.060 µg/mL for MIC50 and MIC90, respectively. The pooled prevalence of tedizolid, telavancin, and dalbavancin susceptibility was 100% (95% CI: 100–100).ConclusionTelavancin, dalbavancin, oritavancin, and tedizolid had potent in vitro activity against MRSA isolates. The low MICs and high susceptibility rates of these antibiotics recommend a hopeful direction to introduce useful antibiotics in treating MRSA infections in the future. More... »

PAGES

37

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12941-022-00529-z

DOI

http://dx.doi.org/10.1186/s12941-022-00529-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1150294307

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35978400


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methicillin-Resistant Staphylococcus aureus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microbial Sensitivity Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Staphylococcal Infections", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Biomedical Engineering, Changzhi Medical College, 046013, Changzhi, Shanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.254020.1", 
          "name": [
            "Department of Biomedical Engineering, Changzhi Medical College, 046013, Changzhi, Shanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Fei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "International Medical Campus, Iran University of Medical Sciences, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411746.1", 
          "name": [
            "International Medical Campus, Iran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rajabi", 
        "givenName": "Sajad", 
        "id": "sg:person.012437426617.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012437426617.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biomedical Engineering, Changzhi Medical College, 046013, Changzhi, Shanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.254020.1", 
          "name": [
            "Department of Biomedical Engineering, Changzhi Medical College, 046013, Changzhi, Shanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shi", 
        "givenName": "Chunhua", 
        "id": "sg:person.011377221361.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011377221361.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411705.6", 
          "name": [
            "Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Afifirad", 
        "givenName": "Ghazale", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran", 
          "id": "http://www.grid.ac/institutes/grid.449129.3", 
          "name": [
            "Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Omidi", 
        "givenName": "Nazanin", 
        "id": "sg:person.014551613471.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014551613471.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Laboratory Sciences, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran", 
          "id": "http://www.grid.ac/institutes/grid.411747.0", 
          "name": [
            "Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran", 
            "Department of Laboratory Sciences, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kouhsari", 
        "givenName": "Ebrahim", 
        "id": "sg:person.01154747377.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154747377.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran", 
          "id": "http://www.grid.ac/institutes/grid.449129.3", 
          "name": [
            "Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khoshnood", 
        "givenName": "Saeed", 
        "id": "sg:person.016064740715.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016064740715.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran", 
          "id": "http://www.grid.ac/institutes/grid.484406.a", 
          "name": [
            "Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Azizian", 
        "givenName": "Khalil", 
        "id": "sg:person.015765071764.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015765071764.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s13756-020-00855-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1134386741", 
          "https://doi.org/10.1186/s13756-020-00855-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-016-2744-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014515940", 
          "https://doi.org/10.1007/s10096-016-2744-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-016-2865-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053838107", 
          "https://doi.org/10.1007/s10096-016-2865-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrmicro3380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047623025", 
          "https://doi.org/10.1038/nrmicro3380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11534440-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048874194", 
          "https://doi.org/10.2165/11534440-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13756-021-00967-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1139278448", 
          "https://doi.org/10.1186/s13756-021-00967-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-017-0623-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100394808", 
          "https://doi.org/10.1007/s40262-017-0623-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ja.2014.30", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018523039", 
          "https://doi.org/10.1038/ja.2014.30"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-08-17", 
    "datePublishedReg": "2022-08-17", 
    "description": "BackgroundMethicillin-resistant Staphylococcus aureus\u00a0(MRSA) infections are considered an important public health problem, and treatment options are limited. Accordingly, in this meta-analysis, we analyzed published studies to survey in vitro activity of recently approved antibiotics against MRSA isolates.MethodsWe searched electronic databases; PubMed, Scopus, and Web of Science to identify relevant studies (until November 30, 2020) that have focused on the in vitro activity of telavancin, dalbavancin, oritavancin, and tedizolid against MRSA isolates. Statistical analyses were conducted using STATA software (version 14.0).ResultsThirty-eight studies were included in this meta-analysis. Overall in vitro activity of tedizolid on 12,204 MRSA isolates was 0.250 and 0.5\u00a0\u00b5g/mL for MIC50 and MIC90, (minimum inhibitory concentration at which 50% and 90% of isolates were inhibited, respectively), respectively. The overall antibacterial activity of dalbavancin on 28539 MRSA isolates was 0.060 and 0.120\u00a0\u00b5g/mL for MIC50 and MIC90, respectively. The overall antibacterial activity of oritavancin on 420 MRSA isolates was 0.045 and 0.120\u00a0\u00b5g/mL for MIC50 and MIC90, respectively. The overall antibacterial activity of telavancin on 7353 MRSA isolates was 0.032 and 0.060\u00a0\u00b5g/mL for MIC50 and MIC90, respectively. The pooled prevalence of tedizolid, telavancin, and dalbavancin susceptibility was 100% (95% CI: 100\u2013100).ConclusionTelavancin, dalbavancin, oritavancin, and tedizolid had potent in vitro activity against MRSA isolates. The low MICs and high susceptibility rates of these antibiotics recommend a hopeful direction to introduce useful antibiotics in treating MRSA infections in the future.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12941-022-00529-z", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031269", 
        "issn": [
          "1476-0711"
        ], 
        "name": "Annals of Clinical Microbiology and Antimicrobials", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "methicillin-resistant Staphylococcus aureus", 
      "MRSA isolates", 
      "overall antibacterial activity", 
      "BackgroundMethicillin-resistant Staphylococcus aureus", 
      "important public health problem", 
      "activity of telavancin", 
      "ResultsThirty-eight studies", 
      "activity of tedizolid", 
      "high susceptibility rates", 
      "public health problem", 
      "Staphylococcus aureus", 
      "Web of Science", 
      "MRSA infection", 
      "pooled prevalence", 
      "treatment options", 
      "susceptibility rates", 
      "useful antibiotic", 
      "electronic databases", 
      "health problems", 
      "systematic review", 
      "MIC90", 
      "dalbavancin susceptibility", 
      "antibacterial activity", 
      "STATA software", 
      "MIC50", 
      "telavancin", 
      "oritavancin", 
      "tedizolid", 
      "relevant studies", 
      "dalbavancin", 
      "lowest MIC", 
      "antibiotics", 
      "infection", 
      "isolates", 
      "mL", 
      "aureus", 
      "statistical analysis", 
      "activity", 
      "PubMed", 
      "prevalence", 
      "MethodsWe", 
      "study", 
      "Scopus", 
      "MIC", 
      "review", 
      "options", 
      "susceptibility", 
      "hopeful directions", 
      "database", 
      "rate", 
      "analysis", 
      "Web", 
      "future", 
      "science", 
      "software", 
      "problem", 
      "direction"
    ], 
    "name": "Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis", 
    "pagination": "37", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1150294307"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12941-022-00529-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35978400"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12941-022-00529-z", 
      "https://app.dimensions.ai/details/publication/pub.1150294307"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_959.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12941-022-00529-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12941-022-00529-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12941-022-00529-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12941-022-00529-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12941-022-00529-z'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      21 PREDICATES      95 URIs      79 LITERALS      12 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12941-022-00529-z schema:about N1390f8c799c44b4fbc528c8cd6094d03
2 N70b8f771f566430595e202f1dc84dc7f
3 N7d64932ba1414cada68b990cf8950656
4 Nb1946c6b44bc48eb96c8185ae40ce05e
5 Ndac19e2e63554f23a9e559f92a01d369
6 anzsrc-for:11
7 anzsrc-for:1103
8 schema:author Nf2984083758b49428bc5caab5fc4db02
9 schema:citation sg:pub.10.1007/s10096-016-2744-3
10 sg:pub.10.1007/s10096-016-2865-8
11 sg:pub.10.1007/s40262-017-0623-4
12 sg:pub.10.1038/ja.2014.30
13 sg:pub.10.1038/nrmicro3380
14 sg:pub.10.1186/s13756-020-00855-x
15 sg:pub.10.1186/s13756-021-00967-y
16 sg:pub.10.2165/11534440-000000000-00000
17 schema:datePublished 2022-08-17
18 schema:datePublishedReg 2022-08-17
19 schema:description BackgroundMethicillin-resistant Staphylococcus aureus (MRSA) infections are considered an important public health problem, and treatment options are limited. Accordingly, in this meta-analysis, we analyzed published studies to survey in vitro activity of recently approved antibiotics against MRSA isolates.MethodsWe searched electronic databases; PubMed, Scopus, and Web of Science to identify relevant studies (until November 30, 2020) that have focused on the in vitro activity of telavancin, dalbavancin, oritavancin, and tedizolid against MRSA isolates. Statistical analyses were conducted using STATA software (version 14.0).ResultsThirty-eight studies were included in this meta-analysis. Overall in vitro activity of tedizolid on 12,204 MRSA isolates was 0.250 and 0.5 µg/mL for MIC50 and MIC90, (minimum inhibitory concentration at which 50% and 90% of isolates were inhibited, respectively), respectively. The overall antibacterial activity of dalbavancin on 28539 MRSA isolates was 0.060 and 0.120 µg/mL for MIC50 and MIC90, respectively. The overall antibacterial activity of oritavancin on 420 MRSA isolates was 0.045 and 0.120 µg/mL for MIC50 and MIC90, respectively. The overall antibacterial activity of telavancin on 7353 MRSA isolates was 0.032 and 0.060 µg/mL for MIC50 and MIC90, respectively. The pooled prevalence of tedizolid, telavancin, and dalbavancin susceptibility was 100% (95% CI: 100–100).ConclusionTelavancin, dalbavancin, oritavancin, and tedizolid had potent in vitro activity against MRSA isolates. The low MICs and high susceptibility rates of these antibiotics recommend a hopeful direction to introduce useful antibiotics in treating MRSA infections in the future.
20 schema:genre article
21 schema:isAccessibleForFree true
22 schema:isPartOf N0851c926b37d4455a078db8a27e715fa
23 N97a8f631529f4e3da52f20b6e567a6bc
24 sg:journal.1031269
25 schema:keywords BackgroundMethicillin-resistant Staphylococcus aureus
26 MIC
27 MIC50
28 MIC90
29 MRSA infection
30 MRSA isolates
31 MethodsWe
32 PubMed
33 ResultsThirty-eight studies
34 STATA software
35 Scopus
36 Staphylococcus aureus
37 Web
38 Web of Science
39 activity
40 activity of tedizolid
41 activity of telavancin
42 analysis
43 antibacterial activity
44 antibiotics
45 aureus
46 dalbavancin
47 dalbavancin susceptibility
48 database
49 direction
50 electronic databases
51 future
52 health problems
53 high susceptibility rates
54 hopeful directions
55 important public health problem
56 infection
57 isolates
58 lowest MIC
59 mL
60 methicillin-resistant Staphylococcus aureus
61 options
62 oritavancin
63 overall antibacterial activity
64 pooled prevalence
65 prevalence
66 problem
67 public health problem
68 rate
69 relevant studies
70 review
71 science
72 software
73 statistical analysis
74 study
75 susceptibility
76 susceptibility rates
77 systematic review
78 tedizolid
79 telavancin
80 treatment options
81 useful antibiotic
82 schema:name Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis
83 schema:pagination 37
84 schema:productId N21606efe113b4a8481f178ef841d6036
85 N7533a233066c42e4b24dee9e551d99ce
86 N9393d694cca94c75870f54d1504bff8e
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1150294307
88 https://doi.org/10.1186/s12941-022-00529-z
89 schema:sdDatePublished 2022-12-01T06:44
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher N020ede2bf68045e595deebd1ed888d21
92 schema:url https://doi.org/10.1186/s12941-022-00529-z
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N020ede2bf68045e595deebd1ed888d21 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N0851c926b37d4455a078db8a27e715fa schema:issueNumber 1
99 rdf:type schema:PublicationIssue
100 N1390f8c799c44b4fbc528c8cd6094d03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Methicillin-Resistant Staphylococcus aureus
102 rdf:type schema:DefinedTerm
103 N19962b83afd7497ca3a4edf3863fef57 rdf:first sg:person.016064740715.34
104 rdf:rest N4107b4f329c34c589213cc824152c71a
105 N21606efe113b4a8481f178ef841d6036 schema:name dimensions_id
106 schema:value pub.1150294307
107 rdf:type schema:PropertyValue
108 N2d55ae9980c348f8bb6d819c40134265 schema:affiliation grid-institutes:grid.254020.1
109 schema:familyName Liu
110 schema:givenName Fei
111 rdf:type schema:Person
112 N4107b4f329c34c589213cc824152c71a rdf:first sg:person.015765071764.18
113 rdf:rest rdf:nil
114 N43663f746c434daf816796cc47805d29 rdf:first sg:person.011377221361.33
115 rdf:rest Nab8f7096549c430388f518e2b4ab17b8
116 N70b8f771f566430595e202f1dc84dc7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Anti-Bacterial Agents
118 rdf:type schema:DefinedTerm
119 N7533a233066c42e4b24dee9e551d99ce schema:name doi
120 schema:value 10.1186/s12941-022-00529-z
121 rdf:type schema:PropertyValue
122 N77ac76d39bde4798a2e791dfa4631781 rdf:first sg:person.014551613471.20
123 rdf:rest Ne52829fdd692442685885e46a1e4352c
124 N7d64932ba1414cada68b990cf8950656 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 N9393d694cca94c75870f54d1504bff8e schema:name pubmed_id
128 schema:value 35978400
129 rdf:type schema:PropertyValue
130 N97a8f631529f4e3da52f20b6e567a6bc schema:volumeNumber 21
131 rdf:type schema:PublicationVolume
132 Na82aca83a1a04182bbc0a6a6d1b466fa rdf:first sg:person.012437426617.63
133 rdf:rest N43663f746c434daf816796cc47805d29
134 Nab8f7096549c430388f518e2b4ab17b8 rdf:first Nde38982f46a6428ca9ee4049b32ed25c
135 rdf:rest N77ac76d39bde4798a2e791dfa4631781
136 Nb1946c6b44bc48eb96c8185ae40ce05e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Microbial Sensitivity Tests
138 rdf:type schema:DefinedTerm
139 Ndac19e2e63554f23a9e559f92a01d369 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Staphylococcal Infections
141 rdf:type schema:DefinedTerm
142 Nde38982f46a6428ca9ee4049b32ed25c schema:affiliation grid-institutes:grid.411705.6
143 schema:familyName Afifirad
144 schema:givenName Ghazale
145 rdf:type schema:Person
146 Ne52829fdd692442685885e46a1e4352c rdf:first sg:person.01154747377.42
147 rdf:rest N19962b83afd7497ca3a4edf3863fef57
148 Nf2984083758b49428bc5caab5fc4db02 rdf:first N2d55ae9980c348f8bb6d819c40134265
149 rdf:rest Na82aca83a1a04182bbc0a6a6d1b466fa
150 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
151 schema:name Medical and Health Sciences
152 rdf:type schema:DefinedTerm
153 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
154 schema:name Clinical Sciences
155 rdf:type schema:DefinedTerm
156 sg:journal.1031269 schema:issn 1476-0711
157 schema:name Annals of Clinical Microbiology and Antimicrobials
158 schema:publisher Springer Nature
159 rdf:type schema:Periodical
160 sg:person.011377221361.33 schema:affiliation grid-institutes:grid.254020.1
161 schema:familyName Shi
162 schema:givenName Chunhua
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011377221361.33
164 rdf:type schema:Person
165 sg:person.01154747377.42 schema:affiliation grid-institutes:grid.411747.0
166 schema:familyName Kouhsari
167 schema:givenName Ebrahim
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154747377.42
169 rdf:type schema:Person
170 sg:person.012437426617.63 schema:affiliation grid-institutes:grid.411746.1
171 schema:familyName Rajabi
172 schema:givenName Sajad
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012437426617.63
174 rdf:type schema:Person
175 sg:person.014551613471.20 schema:affiliation grid-institutes:grid.449129.3
176 schema:familyName Omidi
177 schema:givenName Nazanin
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014551613471.20
179 rdf:type schema:Person
180 sg:person.015765071764.18 schema:affiliation grid-institutes:grid.484406.a
181 schema:familyName Azizian
182 schema:givenName Khalil
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015765071764.18
184 rdf:type schema:Person
185 sg:person.016064740715.34 schema:affiliation grid-institutes:grid.449129.3
186 schema:familyName Khoshnood
187 schema:givenName Saeed
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016064740715.34
189 rdf:type schema:Person
190 sg:pub.10.1007/s10096-016-2744-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014515940
191 https://doi.org/10.1007/s10096-016-2744-3
192 rdf:type schema:CreativeWork
193 sg:pub.10.1007/s10096-016-2865-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053838107
194 https://doi.org/10.1007/s10096-016-2865-8
195 rdf:type schema:CreativeWork
196 sg:pub.10.1007/s40262-017-0623-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100394808
197 https://doi.org/10.1007/s40262-017-0623-4
198 rdf:type schema:CreativeWork
199 sg:pub.10.1038/ja.2014.30 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018523039
200 https://doi.org/10.1038/ja.2014.30
201 rdf:type schema:CreativeWork
202 sg:pub.10.1038/nrmicro3380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047623025
203 https://doi.org/10.1038/nrmicro3380
204 rdf:type schema:CreativeWork
205 sg:pub.10.1186/s13756-020-00855-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1134386741
206 https://doi.org/10.1186/s13756-020-00855-x
207 rdf:type schema:CreativeWork
208 sg:pub.10.1186/s13756-021-00967-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1139278448
209 https://doi.org/10.1186/s13756-021-00967-y
210 rdf:type schema:CreativeWork
211 sg:pub.10.2165/11534440-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048874194
212 https://doi.org/10.2165/11534440-000000000-00000
213 rdf:type schema:CreativeWork
214 grid-institutes:grid.254020.1 schema:alternateName Department of Biomedical Engineering, Changzhi Medical College, 046013, Changzhi, Shanxi, China
215 schema:name Department of Biomedical Engineering, Changzhi Medical College, 046013, Changzhi, Shanxi, China
216 rdf:type schema:Organization
217 grid-institutes:grid.411705.6 schema:alternateName Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
218 schema:name Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
219 rdf:type schema:Organization
220 grid-institutes:grid.411746.1 schema:alternateName International Medical Campus, Iran University of Medical Sciences, Tehran, Iran
221 schema:name International Medical Campus, Iran University of Medical Sciences, Tehran, Iran
222 rdf:type schema:Organization
223 grid-institutes:grid.411747.0 schema:alternateName Department of Laboratory Sciences, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran
224 schema:name Department of Laboratory Sciences, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran
225 Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran
226 rdf:type schema:Organization
227 grid-institutes:grid.449129.3 schema:alternateName Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran
228 schema:name Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran
229 rdf:type schema:Organization
230 grid-institutes:grid.484406.a schema:alternateName Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
231 schema:name Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...